The Global Health Body Issues Concern Over Critical Lack of Weight-Loss Medications

Under 10% of patients that would benefit from obesity jabs including Wegovy are able to get them, states the global health agency as it releases its initial recommendations on the drugs.

With in excess of 1,000,000,000 people worldwide currently living with obesity, it is urging broader and more equitable access to GLP-1 medication.

Based on projections, more than two billion are projected to be obese by 2030 without intervention.

"Our latest guidance acknowledges that obesity is a long-term condition that can be addressed with holistic and continuous support," remarked WHO director-general Tedros Adhanom Ghebreyesus.

High costs, limited production capacity, and distribution challenges are key hurdles to widespread access to the injections that can aid individuals in losing considerable weight, explains the agency.

Weight-Loss Drug Scarcity

Even in the present best projected scenario, the supply of such drugs would only suffice for approximately 100 million people – under 10% of eligible patients, according to the WHO.

The advice calls on governments and firms to widen availability, through strategies including licensing agreements.

Exclusive production rights on a key compound – the primary ingredient of the drug Wegovy – is scheduled to end in several nations in 2026.

The Way Weight-Loss Drugs Function

These medications imitate a natural hormone to reduce digestion speed, suppress the appetite and increase satiety so people consume fewer calories.

People commonly start to lose weight within a few weeks of commencing the regular doses.

Research points to patients may put most of the weight back on after a year of discontinuing the medication, because their usual hunger resume.

To be overweight or obese elevates your chance for contracting medical conditions, including diabetes, heart disease, stroke, and certain cancers.

Obesity affects individuals in countries worldwide and was associated with 3.7 million fatalities worldwide in 2024, according to the WHO.